UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 6, 2004
GLOBAL MED TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter)
Colorado
(State or other jurisdiction of
incorporation or organization) | 0-22083
(Commission File No.) | 84-1116894
(I.R.S. Employer
Identification No.) |
12600 West Colfax, Suite C-420, Lakewood, Colorado 80215
(Address of principal executive offices) (Zip Code)
(303) 238-2000
(Registrant’s telephone number, including area code)
Item 7. Financial Statements and Exhibits.
(c) The following exhibits are furnished herewith:
| 99.1 | | Press release, dated August 6, 2004. |
Item 12. Results of Operations and Financial Condition.
The information in this Form 8-K (including the exhibit hereto) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
| | On August 6, 2004, Global Med Technologies, Inc. issued a press release announcing its results for the three and six months ended June 30, 2004. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | GLOBAL MED TECHNOLOGIES, INC.
By:/s/ Michael I. Ruxin, M.D.
Michael I. Ruxin, M.D.
Chairman and Chief Executive Officer |
Date: August 10, 2004
2
EXHIBIT INDEX
Exhibit No.
| Description
|
|---|
99.1 | | Press release dated August 6, 2004 issued by Global Med Technologies, Inc. | |
3
